New FDA Policies Could Limit the Full Value of AI in Medicine

This JAMA Forum discusses the ways in which recent changes to US Food and Drug Administration (FDA) policies related to the regulation of artificial intelligence (AI) have added new uncertainties for the use of AI tools in medicine.

Authors

Institutions

Publication Details

Journal
JAMA Health Forum
Published
2025-02-06
DOI
https://doi.org/10.1001/jamahealthforum.2025.0289
Citations
5
Primary Topic
Healthcare cost, quality, practices
Type
article
Field-Weighted Citation Impact
14.08
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New FDA Policies Could Limit the Full Value of AI in Medicine

Scott L. Gottlieb
5 citations
JAMA Health Forum
Healthcare cost, quality, practices
14.08
article

New FDA Policies Could Limit the Full Value of AI in Medicine

Scott L. Gottlieb
article en
5 citations

Abstract

This JAMA Forum discusses the ways in which recent changes to US Food and Drug Administration (FDA) policies related to the regulation of artificial intelligence (AI) have added new uncertainties for the use of AI tools in medicine.

JAMA Health ForumVol. 6(2)
American Enterprise Institute (US)
Openalex Percentile: Top 1%
Healthcare cost, quality, practices
14.08
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.